Atogepant: an emerging treatment for migraine.
Sign Up to like & getrecommendations! Published in 2022 at "Expert opinion on pharmacotherapy"
DOI: 10.1080/14656566.2022.2057221
Abstract: INTRODUCTION Until recently, only non-specific and not always well-tolerated medications were available for migraine prophylaxis. Currently, specific drugs such as calcitonin gene-related peptide (CGRP) monoclonal antibodies and second-generation gepants are marketed for migraine treatment. Atogepant,… read more here.
Keywords: episodic migraine; migraine prophylaxis; atogepant; migraine ... See more keywords